Newsletter | August 6, 2025

08.06.25 -- Relationship Equity With CDMOs Is Real, Take It From A Packaging Pro

SPONSOR

From solubility challenges to modified release and pediatric dosage forms, we help sponsors overcome development roadblocks with tailored, scalable solutions. We combine formulation and manufacturing expertise with a sponsor-informed mindset that keeps clinical, regulatory, and commercial goals in focus. At AustinPx, we don’t rely on generic approaches. We collaborate across disciplines to build scientifically sound, strategically aligned formulations. This is where complex challenges meet tailored solutions and where your molecule finds a path that delivers.

INDUSTRY INSIGHTS

Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

Explore the key advantages of stick-pack formats, from enhanced product safety and cost-efficiency to improved compliance and marketability.

Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

As therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable suppliers to secure high-quality starting materials.

Innovative Technology For Developing, Scaling Peptide-Based Therapeutics

Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

FEATURED EDITORIAL

Relationship Equity With CDMOs Is Real, Take It From A Packaging Pro

A professional of packaging who has weaved through positions in Big Pharma says you should understand any points of leverage you have with a CDMO. However, when leverage is minimal, creating "relationship equity" is the key to win-win relationships for sponsor and provider. After a decade, a well-timed follow up conversation with Dan Marasco.

Outsourced, In-House, Or A Combo: An Agile Recruiting Strategy Fuels Growth

There are different staffing options for building an agile and scalable team that can quickly react to shifting needs, resources, and funding.

INDUSTRY INSIGHTS CONTINUED

Integrating Early Development With Clinical Supply

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

Material-Sparing Feasibility Screening For Hot Melt Extrusion

Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

Finding The Ideal Balance — Where Risk And Cost Of Quality Meet

It is a challenge to keep improving product value for customers while reducing overall costs. Part of the solution resides in the functional activities of the risk involved and the cost of quality management.

SOLUTIONS

From Concept To Clinic: Expert Formulation Services That Deliver

Examine industry-leading formulation services for small molecules designed to support every stage of development—from preclinical through clinical trials to commercialization.

PBPK Predictive Modeling Services

Early identification of potential absorption risks is critical for rapid and efficient drug development. Learn how our services can de-risk your drug development program.

ADHD Awareness: How This Novel Technology Can Guide The Way

Observe an innovative nanoparticle technology and the value it can bring to molecules in development or products on the market for neurological disorders.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: